198 filings
Page 7 of 10
6-K
ioye4
19 Oct 21
FSD Pharma Inc. 6-K
8:30am
6-K
2jzpp20vqoahie0t17c7
27 Sep 21
Material Change Report
12:00am
6-K
jqp1kdtn21ywk0
23 Sep 21
FSD Pharma Inc. Form 6-K
7:21am
6-K
0cqmf186
21 Sep 21
THIS AGREEMENT made as of the 25th day of August, 2021
4:02pm
6-K
5nxisuwgtr3vxpxgv7j
31 Aug 21
Material Change Report
2:06pm
6-K
3cv24putwwsygbdf7x70
25 Aug 21
FSD Pharma Inc. 6-K
9:00am
6-K
umnqcyxl
25 Aug 21
Acquisition Advances Company’s Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical Cannabis
9:00am
6-K
q0642 4gqv5
12 Aug 21
Management's Discussion and Analysis of Financial Condition and Results of
9:53pm
6-K
0nbgpo
27 Jul 21
Appoints Anthony Durkacz as Interim Chief Executive Officer and Reinstates Zeeshan Saeed as President
9:24am
6-K
jrm myxbxh2usqm
3 Jun 21
FSD Pharma Inc. 6-K
9:20am
6-K
094k8y5b m3
17 May 21
FSD Pharma Inc. 6-K
8:08am
6-K
f75mjop
13 May 21
FSD Pharma Inc. 6-K
10:32am
6-K
1f54mqccsij0o2tc9j
10 May 21
FSD Pharma Inc. 6-K
8:30am
6-K
s8i9 u3bjow1
7 May 21
Condensed consolidated interim financial statements
4:38pm
6-K
sshho
5 May 21
FSD Pharma Inc. Form 6-K
5:01pm
6-K
ydnp5 gyvxfw1
5 May 21
Current report (foreign)
11:30am
6-K
s2o57mi06t ql
5 May 21
FSD Pharma Inc. 6-K
8:54am
6-K
chzdat5mhiqp30hd
3 May 21
FSD Pharma Inc. 6-K
7:30am
6-K
q6p jlrws46
23 Apr 21
Current report (foreign)
5:24pm
6-K
9dgru b7r
23 Apr 21
FSD Pharma Inc. Form 6-K
9:02am